{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:42:04Z","timestamp":1786624924325,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beckman Coulter"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early diagnosis and treatment of patients with sepsis reduce mortality significantly. In terms of exploring new diagnostic tools of sepsis, monocyte distribution width (MDW), as part of the white blood cell (WBC) differential count, was first reported in 2017. MDW greater than 20 and abnormal WBC count together provided a satisfactory accuracy and was proposed as a novel diagnostic tool of sepsis. This study aimed to compare MDW and procalcitonin (PCT)\u2019s diagnostic accuracy on sepsis in the emergency department.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a single-center prospective cohort study. Laboratory examinations including complete blood cell and differentiation count (CBC\/DC), MDW, PCT were obtained while arriving at the ED. We divided patients into non-infection, infection without systemic inflammatory response syndrome (SIRS), infection with SIRS, and sepsis-3 groups. This study\u2019s primary outcome is the sensitivity and specificity of MDW, PCT, and MDW\u2009+\u2009WBC in differentiating septic and non-septic patients. In addition, the cut-off value for MDW was established to maximize sensitivity at an optimal level of specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From May 2019 to September 2020, 402 patients were enrolled for data analysis. Patient number in each group was: non-infection 64 (15.9%), infection without SIRS 82 (20.4%), infection with SIRS 202 (50.2%), sepsis-3 15 (7.6%). The AUC of MDW, PCT, and MDW\u2009+\u2009WBC to predict infection with SIRS was 0.753, 0.704, and 0.784, respectively (p\u2009&lt;\u20090.01). The sensitivity, specificity, PPV, and NPV of MDW using 20 as the cutoff were 86.4%, 54.2%, 76.4%, and 70%, compared to 32.9%, 88%, 82.5%, and 43.4% using 0.5\u00a0ng\/mL as the PCT cutoff value. On combing MDW and WBC count, the sensitivity and NPV further increased to 93.4% and 80.3%, respectively. In terms of predicting sepsis-3, the AUC of MDW, PCT, and MDW\u2009+\u2009WBC was 0.72, 0.73, and 0.70, respectively. MDW, using 20 as cutoff, exhibited sensitivity, specificity, PPV, and NPV of 90.6%, 37.1%, 18.7%, and 96.1%, respectively, compared to 49.1%, 78.6%, 26.8%, and 90.6% when 0.5\u00a0ng\/mL PCT was used as cutoff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, MDW is a more sensitive biomarker than PCT in predicting infection-related SIRS and sepsis-3 in the ED. MDW\u2009&lt;\u200920 shows a higher NPV to exclude sepsis-3. Combining MDW and WBC count further improves the accuracy in predicting infection with SIRS but not sepsis-3.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      The study was retrospectively registered to the ClinicalTrial.gov (NCT04322942) on March 26th, 2020.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06999-4","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:05:09Z","timestamp":1641276309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Comparison of the diagnostic accuracy of monocyte distribution width and procalcitonin in sepsis cases in the emergency department: a prospective cohort study"],"prefix":"10.1186","volume":"22","clinical-trial-number":[{"clinical-trial-number":"nct04322942","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chih-Huang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-June","family":"Seak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsien","family":"Chaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse\u2010Hsuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0363-2938","authenticated-orcid":false,"given":"Chip-Jin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"issue":"8","key":"6999_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, J Am Med Assoc. 2016;315(8):801\u201310.","journal-title":"JAMA, J Am Med Assoc"},{"issue":"8","key":"6999_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, J Am Med Assoc. 2016;315(8):762\u201374.","journal-title":"JAMA, J Am Med Assoc"},{"issue":"8","key":"6999_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2016.0289","volume":"315","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M, Sepsis Definitions Task F. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA, J Am Med Assoc. 2016;315(8):775\u201387.","journal-title":"JAMA, J Am Med Assoc"},{"key":"6999_CR4","doi-asserted-by":"crossref","unstructured":"Focus on sepsis. Nat Med. 2012;18(7):997.","DOI":"10.1038\/nm0712-997"},{"issue":"9","key":"6999_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"6999_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"6","key":"6999_CR7","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"8","key":"6999_CR8","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, Artigas A, Schorr C, Levy MM. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749\u201355.","journal-title":"Crit Care Med"},{"issue":"4","key":"6999_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CCM.0b013e3181cc4824","volume":"38","author":"DF Gaieski","year":"2010","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, Shofer FS, Goyal M. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38(4):1045\u201353.","journal-title":"Crit Care Med"},{"issue":"1","key":"6999_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2015.08.039","volume":"34","author":"GE Hayden","year":"2016","unstructured":"Hayden GE, Tuuri RE, Scott R, Losek JD, Blackshaw AM, Schoenling AJ, Nietert PJ, Hall GA. Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED. Am J Emerg Med. 2016;34(1):1\u20139.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"6999_CR11","first-page":"121","volume":"18","author":"CH Li","year":"2011","unstructured":"Li CH, Yang RB, Pang JH, Chang SS, Lin CC, Chen CH, Chen HY, Chiu TF. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med. 2011;18(2):121\u20136.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"6999_CR12","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/cc2396","volume":"8","author":"YL Chan","year":"2004","unstructured":"Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care. 2004;8(1):R12-20.","journal-title":"Crit Care"},{"key":"6999_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejim.2020.04.055","volume":"79","author":"M Covino","year":"2020","unstructured":"Covino M, Piccioni A, Bonadia N, Onder G, Sabia L, Carbone L, Candelli M, Ojetti V, Murri R, Franceschi F. Early procalcitonin determination in the emergency department and clinical outcome of community-acquired pneumonia in old and oldest old patients. Eur J Intern Med. 2020;79:51\u20137.","journal-title":"Eur J Intern Med"},{"key":"6999_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2147\/COPD.S76740","volume":"10","author":"CH Chang","year":"2015","unstructured":"Chang CH, Tsao KC, Hu HC, Huang CC, Kao KC, Chen NH, Yang CT, Tsai YH, Hsieh MJ. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits. Int J Chron Obstruct Pulmon Dis. 2015;10:767\u201374.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"6999_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s00134-012-2563-7","volume":"38","author":"DK Matthaiou","year":"2012","unstructured":"Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Med. 2012;38(6):940\u20139.","journal-title":"Intensive Care Med"},{"issue":"6","key":"6999_CR16","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1186\/cc13157","volume":"17","author":"A Prkno","year":"2013","unstructured":"Prkno A, Wacker C, Brunkhorst FM, Schlattmann P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock\u2014a systematic review and meta-analysis. Crit Care. 2013;17(6):R291.","journal-title":"Crit Care"},{"key":"6999_CR17","doi-asserted-by":"crossref","unstructured":"Westwood M, Ramaekers B, Whiting P, Tomini F, Joore M, Armstrong N, Ryder S, Stirk L, Severens J, Kleijnen J. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(96):v\u2013xxv, 1\u2013236.","DOI":"10.3310\/hta19960"},{"key":"6999_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40560-019-0374-4","volume":"7","author":"Y Kondo","year":"2019","unstructured":"Kondo Y, Umemura Y, Hayashida K, Hara Y, Aihara M, Yamakawa K. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care. 2019;7:22.","journal-title":"J Intensive Care"},{"issue":"9","key":"6999_CR19","doi-asserted-by":"publisher","first-page":"e22996","DOI":"10.1002\/jcla.22996","volume":"33","author":"DW Jekarl","year":"2019","unstructured":"Jekarl DW, Lee S, Kim M, Kim Y, Woo SH, Lee WJ. Procalcitonin as a prognostic marker for sepsis based on SEPSIS-3. J Clin Lab Anal. 2019;33(9):e22996.","journal-title":"J Clin Lab Anal"},{"issue":"10","key":"6999_CR20","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1007\/s00520-015-2650-8","volume":"23","author":"CW Wu","year":"2015","unstructured":"Wu CW, Wu JY, Chen CK, Huang SL, Hsu SC, Lee MT, Chang SS, Lee CC. Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer. 2015;23(10):2863\u201372.","journal-title":"Support Care Cancer"},{"key":"6999_CR21","doi-asserted-by":"crossref","first-page":"e23478","DOI":"10.1002\/jcla.23478","volume":"34","author":"X Li","year":"2020","unstructured":"Li X, Wu J, Mao W. Evaluation of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, and red cell distribution width for the prediction of prognosis of patients with hepatitis B virus-related decompensated cirrhosis. J Clin Lab Anal. 2020;34:e23478.","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"6999_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14712\/18059694.2019.132","volume":"62","author":"C Kadiyoran","year":"2019","unstructured":"Kadiyoran C, Zengin O, Cizmecioglu HA, Tufan A, Kucuksahin O, Cure MC, Cure E, Kucuk A, Ozturk MA. Monocyte to lymphocyte ratio, neutrophil to lymphocyte ratio, and red cell distribution width are the associates with gouty arthritis. Acta Medica (Hradec Kralove). 2019;62(3):99\u2013104.","journal-title":"Acta Medica (Hradec Kralove)"},{"issue":"1","key":"6999_CR23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3889\/oamjms.2017.007","volume":"5","author":"C Sahin","year":"2017","unstructured":"Sahin C, Varim C. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume and red cell distribution width measures in bells palsy. Open Access Maced J Med Sci. 2017;5(1):14\u20138.","journal-title":"Open Access Maced J Med Sci"},{"issue":"1","key":"6999_CR24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12879-019-4618-7","volume":"19","author":"J Song","year":"2019","unstructured":"Song J, Park DW, Moon S, Cho HJ, Park JH, Seok H, Choi WS. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19(1):968.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"6999_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/cc12693","volume":"17","author":"S Skibsted","year":"2013","unstructured":"Skibsted S, Bhasin MK, Aird WC, Shapiro NI. Bench-to-bedside review: future novel diagnostics for sepsis - a systems biology approach. Crit Care. 2013;17(5):231.","journal-title":"Crit Care"},{"issue":"1","key":"6999_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/pr.2011.16","volume":"71","author":"IH Celik","year":"2012","unstructured":"Celik IH, Demirel G, Aksoy HT, Erdeve O, Tuncer E, Biyikli Z, Dilmen U. Automated determination of neutrophil VCS parameters in diagnosis and treatment efficacy of neonatal sepsis. Pediatr Res. 2012;71(1):121\u20135.","journal-title":"Pediatr Res"},{"issue":"3","key":"6999_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5045\/br.2013.48.3.193","volume":"48","author":"AJ Lee","year":"2013","unstructured":"Lee AJ, Kim SG. Mean cell volumes of neutrophils and monocytes are promising markers of sepsis in elderly patients. Blood Res. 2013;48(3):193\u20137.","journal-title":"Blood Res"},{"issue":"3","key":"6999_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.chest.2017.05.039","volume":"152","author":"ED Crouser","year":"2017","unstructured":"Crouser ED, Parrillo JE, Seymour C, Angus DC, Bicking K, Tejidor L, Magari R, Careaga D, Williams J, Closser DR, et al. Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker. Chest. 2017;152(3):518\u201326.","journal-title":"Chest"},{"issue":"8","key":"6999_CR29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/CCM.0000000000003799","volume":"47","author":"ED Crouser","year":"2019","unstructured":"Crouser ED, Parrillo JE, Seymour CW, Angus DC, Bicking K, Esguerra VG, Peck-Palmer OM, Magari RT, Julian MW, Kleven JM, et al. Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients. Crit Care Med. 2019;47(8):1018\u201325.","journal-title":"Crit Care Med"},{"key":"6999_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40560-020-00446-3","volume":"8","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Parrillo JE, Martin GS, Huang DT, Hausfater P, Grigorov I, Careaga D, Osborn T, Hasan M, Tejidor L. Monocyte distribution width enhances early sepsis detection in the emergency department beyond SIRS and qSOFA. J Intensive Care. 2020;8:33.","journal-title":"J Intensive Care"},{"issue":"1","key":"6999_CR31","doi-asserted-by":"publisher","first-page":"e0227300","DOI":"10.1371\/journal.pone.0227300","volume":"15","author":"E Polilli","year":"2020","unstructured":"Polilli E, Sozio F, Frattari A, Persichitti L, Sensi M, Posata R, Di Gregorio M, Sciacca A, Flacco ME, Manzoli L, et al. Comparison of monocyte distribution width (MDW) and procalcitonin for early recognition of sepsis. PLoS ONE. 2020;15(1):e0227300.","journal-title":"PLoS ONE"},{"issue":"9","key":"6999_CR32","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1097\/CCM.0000000000004449","volume":"48","author":"M Engoren","year":"2020","unstructured":"Engoren M, Seelhammer T, Freundlich RE, Maile MD, Sigakis MJG, Schwann TA. A comparison of sepsis-2 (systemic inflammatory response syndrome based) to sepsis-3 (sequential organ failure assessment based) definitions-a multicenter retrospective study. Crit Care Med. 2020;48(9):1258\u201364.","journal-title":"Crit Care Med"},{"issue":"6","key":"6999_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1097\/SHK.0000000000001460","volume":"53","author":"HA Lindner","year":"2020","unstructured":"Lindner HA, Kirschning T, Fairley AM, Oster ME, Weiss C, Schneider-Lindner V. Earlier recognition of sepsis and septic shock with sepsis-3 criteria\u2014it\u2019s still early days! Shock. 2020;53(6):779\u201380.","journal-title":"Shock"},{"issue":"5","key":"6999_CR34","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.21037\/jtd.2019.04.90","volume":"11","author":"H Tian","year":"2019","unstructured":"Tian H, Zhou J, Weng L, Hu X, Peng J, Wang C, Jiang W, Du X, Xi X, An Y, et al. Accuracy of qSOFA for the diagnosis of sepsis-3: a secondary analysis of a population-based cohort study. J Thorac Dis. 2019;11(5):2034\u201342.","journal-title":"J Thorac Dis"},{"issue":"10","key":"6999_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/CCM.0b013e31828e969f","volume":"41","author":"CF Oliveira","year":"2013","unstructured":"Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, Nobre V. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med. 2013;41(10):2336\u201343.","journal-title":"Crit Care Med"},{"issue":"1","key":"6999_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12894-020-00596-4","volume":"20","author":"M Tambo","year":"2020","unstructured":"Tambo M, Taguchi S, Nakamura Y, Okegawa T, Fukuhara H. Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis. BMC Urol. 2020;20(1):23.","journal-title":"BMC Urol"},{"issue":"1","key":"6999_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1373\/jalm.2019.029777","volume":"5","author":"JAH van Oers","year":"2020","unstructured":"van Oers JAH, de Jong E, Kemperman H, Girbes ARJ, de Lange DW. diagnostic accuracy of procalcitonin and C-reactive protein is insufficient to predict proven infection: a retrospective cohort study in critically ill patients fulfilling the sepsis-3 criteria. J Appl Lab Med. 2020;5(1):62\u201372.","journal-title":"J Appl Lab Med"},{"issue":"4","key":"6999_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jinf.2012.06.004","volume":"65","author":"M Tromp","year":"2012","unstructured":"Tromp M, Lansdorp B, Bleeker-Rovers CP, Gunnewiek JM, Kullberg BJ, Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect. 2012;65(4):292\u2013301.","journal-title":"J Infect"},{"issue":"6","key":"6999_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/SHK.0b013e31823533f9","volume":"36","author":"J Guan","year":"2011","unstructured":"Guan J, Lin Z, Lue H. Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng\/mL. Shock. 2011;36(6):570\u20134.","journal-title":"Shock"},{"issue":"1","key":"6999_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871526515666150320162950","volume":"15","author":"V Avrillon","year":"2015","unstructured":"Avrillon V, Locatelli-Sanchez M, Folliet L, Carbonnaux M, Perino E, Fossard G, Desseigne M, Freymond N, Geriniere L, Perrot E, et al. Lung cancer may increase serum procalcitonin level. Infect Disord Drug Targets. 2015;15(1):57\u201363.","journal-title":"Infect Disord Drug Targets"},{"issue":"18","key":"6999_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.clinbiochem.2014.09.002","volume":"47","author":"M Patout","year":"2014","unstructured":"Patout M, Salaun M, Brunel V, Bota S, Cauliez B, Thiberville L. Diagnostic and prognostic value of serum procalcitonin concentrations in primary lung cancers. Clin Biochem. 2014;47(18):263\u20137.","journal-title":"Clin Biochem"},{"issue":"4975","key":"6999_CR42","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1126\/science.1698311","volume":"249","author":"SD Wright","year":"1990","unstructured":"Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249(4975):1431\u20133.","journal-title":"Science"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06999-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06999-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T03:39:45Z","timestamp":1700019585000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06999-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6999"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06999-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-410760\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institution Review Board of Chang Gung Memorial Hospital (No. 201900442B0) and registered to the ClinicalTrial.gov (NCT04322942). Written consent was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}